These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 24361916)

  • 1. Spinal gene expression profiling and pathways analysis of a CB2 agonist (MDA7)-targeted prevention of paclitaxel-induced neuropathy.
    Xu JJ; Diaz P; Bie B; Astruc-Diaz F; Wu J; Yang H; Brown DL; Naguib M
    Neuroscience; 2014 Feb; 260():185-94. PubMed ID: 24361916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of paclitaxel-induced neuropathy through activation of the central cannabinoid type 2 receptor system.
    Naguib M; Xu JJ; Diaz P; Brown DL; Cogdell D; Bie B; Hu J; Craig S; Hittelman WN
    Anesth Analg; 2012 May; 114(5):1104-20. PubMed ID: 22392969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabinoid Type 2 Receptor System Modulates Paclitaxel-Induced Microglial Dysregulation and Central Sensitization in Rats.
    Wu J; Hocevar M; Bie B; Foss JF; Naguib M
    J Pain; 2019 May; 20(5):501-514. PubMed ID: 30414958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MDA7: a novel selective agonist for CB2 receptors that prevents allodynia in rat neuropathic pain models.
    Naguib M; Diaz P; Xu JJ; Astruc-Diaz F; Craig S; Vivas-Mejia P; Brown DL
    Br J Pharmacol; 2008 Dec; 155(7):1104-16. PubMed ID: 18846037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabinoid agonist WIN 55,212-2 prevents the development of paclitaxel-induced peripheral neuropathy in rats. Possible involvement of spinal glial cells.
    Burgos E; Gómez-Nicola D; Pascual D; Martín MI; Nieto-Sampedro M; Goicoechea C
    Eur J Pharmacol; 2012 May; 682(1-3):62-72. PubMed ID: 22374260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of cannabinoid receptor 2 attenuates mechanical allodynia and neuroinflammatory responses in a chronic post-ischemic pain model of complex regional pain syndrome type I in rats.
    Xu J; Tang Y; Xie M; Bie B; Wu J; Yang H; Foss JF; Yang B; Rosenquist RW; Naguib M
    Eur J Neurosci; 2016 Dec; 44(12):3046-3055. PubMed ID: 27717112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiallodynic effect of β-caryophyllene on paclitaxel-induced peripheral neuropathy in mice.
    Segat GC; Manjavachi MN; Matias DO; Passos GF; Freitas CS; Costa R; Calixto JB
    Neuropharmacology; 2017 Oct; 125():207-219. PubMed ID: 28729222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic cannabinoid administration blocks the development of paclitaxel-induced neuropathic nociception during analgesic treatment and following cessation of drug delivery.
    Rahn EJ; Deng L; Thakur GA; Vemuri K; Zvonok AM; Lai YY; Makriyannis A; Hohmann AG
    Mol Pain; 2014 Apr; 10():27. PubMed ID: 24742127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic cannabinoid receptor 2 activation reverses paclitaxel neuropathy without tolerance or cannabinoid receptor 1-dependent withdrawal.
    Deng L; Guindon J; Cornett BL; Makriyannis A; Mackie K; Hohmann AG
    Biol Psychiatry; 2015 Mar; 77(5):475-87. PubMed ID: 24853387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The maintenance of cisplatin- and paclitaxel-induced mechanical and cold allodynia is suppressed by cannabinoid CB₂ receptor activation and independent of CXCR4 signaling in models of chemotherapy-induced peripheral neuropathy.
    Deng L; Guindon J; Vemuri VK; Thakur GA; White FA; Makriyannis A; Hohmann AG
    Mol Pain; 2012 Sep; 8():71. PubMed ID: 22998838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-regulation of CX3CL1 via Nuclear Factor-κB-dependent Histone Acetylation Is Involved in Paclitaxel-induced Peripheral Neuropathy.
    Li D; Huang ZZ; Ling YZ; Wei JY; Cui Y; Zhang XZ; Zhu HQ; Xin WJ
    Anesthesiology; 2015 May; 122(5):1142-51. PubMed ID: 25494456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripherally administered cannabinoid receptor 2 (CB
    Wilkerson JL; Alberti LB; Thakur GA; Makriyannis A; Milligan ED
    Brain Res; 2022 Jan; 1774():147721. PubMed ID: 34774500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose cannabinoid receptor 2 agonist induces microglial activation in a cancer pain-morphine tolerance rat model.
    Ma C; Zhang M; Liu L; Zhang P; Liu D; Zheng X; Zhong X; Wang G
    Life Sci; 2021 Jan; 264():118635. PubMed ID: 33131746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A3 adenosine receptor agonist prevents the development of paclitaxel-induced neuropathic pain by modulating spinal glial-restricted redox-dependent signaling pathways.
    Janes K; Esposito E; Doyle T; Cuzzocrea S; Tosh DK; Jacobson KA; Salvemini D
    Pain; 2014 Dec; 155(12):2560-2567. PubMed ID: 25242567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rikkunshito prevents paclitaxel-induced peripheral neuropathy through the suppression of the nuclear factor kappa B (NFκB) phosphorylation in spinal cord of mice.
    Kamei J; Hayashi S; Sakai A; Nakanishi Y; Kai M; Ikegami M; Ikeda H
    PLoS One; 2017; 12(2):e0171819. PubMed ID: 28182729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective activation of cannabinoid CB2 receptors suppresses neuropathic nociception induced by treatment with the chemotherapeutic agent paclitaxel in rats.
    Rahn EJ; Zvonok AM; Thakur GA; Khanolkar AD; Makriyannis A; Hohmann AG
    J Pharmacol Exp Ther; 2008 Nov; 327(2):584-91. PubMed ID: 18664590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of CB
    Wu J; Hocevar M; Foss JF; Bie B; Naguib M
    Eur J Pharmacol; 2017 Sep; 811():12-20. PubMed ID: 28551012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-inflammatory protein TSG-6 secreted by bone marrow mesenchymal stem cells attenuates neuropathic pain by inhibiting the TLR2/MyD88/NF-κB signaling pathway in spinal microglia.
    Yang H; Wu L; Deng H; Chen Y; Zhou H; Liu M; Wang S; Zheng L; Zhu L; Lv X
    J Neuroinflammation; 2020 May; 17(1):154. PubMed ID: 32393298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NF-κB, ERK, p38 MAPK and JNK contribute to the initiation and/or maintenance of mechanical allodynia induced by tumor necrosis factor-alpha in the red nucleus.
    Zhang Q; Wang J; Duan MT; Han SP; Zeng XY; Wang JY
    Brain Res Bull; 2013 Oct; 99():132-9. PubMed ID: 24161765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spinal cannabinoid receptor type 2 agonist reduces mechanical allodynia and induces mitogen-activated protein kinase phosphatases in a rat model of neuropathic pain.
    Landry RP; Martinez E; DeLeo JA; Romero-Sandoval EA
    J Pain; 2012 Sep; 13(9):836-48. PubMed ID: 22901764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.